GlassScriptPhysician profile
Daniel E Thompson
NPI 1265457550
$3,518.30
in general payments reported to CMS, 2019-2025
10 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $46.52 · 2021: $65.50 · 2022: $1,251 · 2023: $214 · 2024: $610 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Travel and Lodging: $553 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.41 |
| Travel and Lodging | $552.96 |
| Education | $134.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $858.47 | 2020-2025 | Oxford, Oxford Partial Knee |
| Smith+Nephew, INC. | $813.45 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Ultrabutton, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Globus Medical, INC. | $173.35 | 2025 | Senza |
| Becton, Dickinson and Company | $120.34 | 2024 | Denali Vena Cava Filter |
| Spine Wave, INC. | $103.92 | 2025 | Spinal Implant |
| Linkbio Corp | $82.52 | 2024 | |
| Depuy Synthes Sales INC. | $76.40 | 2021-2025 | Orthovisc, Monovisc |
| Vericel Corporation | $62.90 | 2024-2025 | Maci |
| Otsuka America Pharmaceutical, INC. | $26.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.